Marisa Wexler, MS, Senior Science Writer —

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

Articles by Marisa Wexler

CHOLESTASIS

February 6, 2024 News by Marisa Wexler, MS

New study finds PFIC3 marked by increased inflammation in liver

In a wide-ranging analysis of thousands of different proteins from liver samples from transplant patients, a team of scientists in Spain discovered potential links to…

FATTY LIVER DISEASE

February 5, 2024 News by Marisa Wexler, MS

Denifanstat seen to safely treat NASH in Phase 2b clinical trial

Denifanstat, Sagimet Biosciences’ experimental therapy, outperformed a placebo at resolving nonalcoholic steatohepatitis (NASH) — a severe form of fatty liver disease —…

Marisa Wexler, MS, Senior Science Writer —

Articles by Marisa Wexler

New study finds PFIC3 marked by increased inflammation in liver

Denifanstat seen to safely treat NASH in Phase 2b clinical trial

Recent Posts